NCT04761107Active, not recruiting
Impact of COVID-19 on GU Disease
Mitigating Risk of COVID-19 for Clinical Management of Genitourinary Diseases
Source: ClinicalTrials.gov · Last updated 31 Jan 2025
Brief summary (registry, in English)
The purpose of this research study is to identify patients with GU disease with active or past COVID-19 infection. Participants will be asked to: * Complete an Online COVID-19 Questionnaire. * Disclose if the patient has or had Genitourinary cancer or benign urologic condition * Provide urine specimen for research * Provide 4 tablespoons of blood for testing blood for research. * Provide permission to access medical records, such as patient lab results, medical history, imaging reports, etc.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 15240 (actual)
- First submitted
- 17 Feb 2021
- Start date
- 18 Feb 2021
- Primary completion date
- 28 Feb 2026
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Diseases
- Prostate cancer, Kidney cancer, Bladder cancer
- NCT number
- NCT04761107
What you commit to
- Study type: Observational
- Participants enrolled: 15240
- From 18 Feb 2021 to the primary completion date, 28 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects do not have a GU disease
Age
- Men and women below 40 years of age
Who the study is looking for
- Subjects must be men and women 40 years of age or older
- Subjects at risk or with GU cancer (Prostate, Bladder, Kidney)
- Subjects with benign GU disorders ( BPH, UTI, Bladder infection and kidney stone)
- Subjects must have a GU disease that requires clinic visit as determined by physician or healthcare provider following a telehealth appointment
- Willing and able to provide blood and urine samples
- Willing and able to complete a questionnaire to determine the COVID-19 symptoms.
- Willing and able to sign informed consent form
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.